NL2000284A1 - Pyrazine-derivaten. - Google Patents

Pyrazine-derivaten.

Info

Publication number
NL2000284A1
NL2000284A1 NL2000284A NL2000284A NL2000284A1 NL 2000284 A1 NL2000284 A1 NL 2000284A1 NL 2000284 A NL2000284 A NL 2000284A NL 2000284 A NL2000284 A NL 2000284A NL 2000284 A1 NL2000284 A1 NL 2000284A1
Authority
NL
Netherlands
Prior art keywords
pyrazine derivatives
pyrazine
derivatives
Prior art date
Application number
NL2000284A
Other languages
English (en)
Other versions
NL2000284C2 (nl
Inventor
Karl Richard Gibson
Cedric Poinsard
Melanie Susanne Glossop
Stephen Mark Denton
Mark Ian Kemp
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of NL2000284A1 publication Critical patent/NL2000284A1/nl
Application granted granted Critical
Publication of NL2000284C2 publication Critical patent/NL2000284C2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
NL2000284A 2005-11-04 2006-10-20 Pyrazine-derivaten. NL2000284C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73366205P 2005-11-04 2005-11-04
US73366205 2005-11-04

Publications (2)

Publication Number Publication Date
NL2000284A1 true NL2000284A1 (nl) 2007-05-07
NL2000284C2 NL2000284C2 (nl) 2007-09-28

Family

ID=37890558

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2000284A NL2000284C2 (nl) 2005-11-04 2006-10-20 Pyrazine-derivaten.

Country Status (27)

Country Link
US (1) US7572797B2 (nl)
EP (1) EP1945630B1 (nl)
JP (1) JP2009514937A (nl)
KR (1) KR20080066073A (nl)
CN (1) CN101356169A (nl)
AP (1) AP2008004468A0 (nl)
AR (1) AR057855A1 (nl)
AT (1) ATE525372T1 (nl)
AU (1) AU2006310215A1 (nl)
BR (1) BRPI0618129A2 (nl)
CA (1) CA2624621C (nl)
CR (1) CR9954A (nl)
DO (1) DOP2006000243A (nl)
EA (1) EA200801011A1 (nl)
EC (1) ECSP088412A (nl)
ES (1) ES2371932T3 (nl)
GT (1) GT200600475A (nl)
IL (1) IL191059A0 (nl)
MA (1) MA29926B1 (nl)
NL (1) NL2000284C2 (nl)
NO (1) NO20082496L (nl)
PE (1) PE20070715A1 (nl)
TN (1) TNSN08196A1 (nl)
TW (1) TW200804353A (nl)
UY (1) UY29893A1 (nl)
WO (1) WO2007052123A2 (nl)
ZA (1) ZA200803671B (nl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934061B3 (en) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
EP1741708A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US20100227872A1 (en) * 2007-05-03 2010-09-09 Mark Ian Kemp Pyrazine derivatives
EA015952B1 (ru) 2007-05-03 2011-12-30 Пфайзер Лимитед 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
WO2009026434A1 (en) * 2007-08-21 2009-02-26 Alkermes, Inc. Pulmonary pharmaceutical formulations
BRPI0820669A2 (pt) 2007-12-10 2020-08-04 Novartis Ag compostos orgânicos
JPWO2009101917A1 (ja) 2008-02-13 2011-06-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 ビシクロアミン誘導体
JP5791500B2 (ja) 2008-05-23 2015-10-07 パンミラ ファーマシューティカルズ，エルエルシー． ５−リポキシゲナーゼ活性化タンパク質阻害剤
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) * 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
ES2645984T3 (es) * 2012-04-25 2017-12-11 Raqualia Pharma Inc Derivados de pirrolopiridinona como bloqueadores de TTX-S
EP3495359A1 (en) 2013-02-04 2019-06-12 Janssen Pharmaceutica NV Flap modulators
TWI644899B (zh) 2013-02-04 2018-12-21 健生藥品公司 Ｆｌａｐ調節劑
CA2960274A1 (en) * 2014-09-10 2016-03-17 Epizyme, Inc. Isoxazole carboxamide compounds
TWI771269B (zh) 2015-02-27 2022-07-21 美商鈣系醫藥公司 胰腺炎治療
CA2995094A1 (en) * 2015-08-07 2017-02-16 Calcimedica, Inc. Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds
CA3172249A1 (en) 2020-03-20 2021-09-23 Calcimedica, Inc. Methods and compositions for treating acute lung injury and acute respiratory distress syndrome
JP7791898B2 (ja) 2020-11-13 2025-12-24 カルシメディカ，インク． Ｃｒａｃチャネル阻害剤の合成の改善

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
DE60234269D1 (de) * 2001-11-21 2009-12-17 Pharmacia & Upjohn Co Llc Substituierte aryl 1,4-pyrazin derivate
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2543644A1 (en) * 2003-10-27 2005-05-06 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
CN101084208A (zh) * 2004-10-22 2007-12-05 詹森药业有限公司 作为c－fms激酶抑制剂的芳族酰胺

Also Published As

Publication number Publication date
ZA200803671B (en) 2009-03-25
TW200804353A (en) 2008-01-16
MA29926B1 (fr) 2008-11-03
PE20070715A1 (es) 2007-08-11
CR9954A (es) 2008-05-28
EA200801011A1 (ru) 2009-02-27
ATE525372T1 (de) 2011-10-15
CA2624621C (en) 2010-11-30
WO2007052123A2 (en) 2007-05-10
DOP2006000243A (es) 2007-05-31
EP1945630A2 (en) 2008-07-23
GT200600475A (es) 2007-07-06
US20070105872A1 (en) 2007-05-10
BRPI0618129A2 (pt) 2011-08-16
TNSN08196A1 (fr) 2009-10-30
NO20082496L (no) 2008-07-24
EP1945630B1 (en) 2011-09-21
JP2009514937A (ja) 2009-04-09
ECSP088412A (es) 2008-05-30
AU2006310215A1 (en) 2007-05-10
UY29893A1 (es) 2007-06-29
ES2371932T3 (es) 2012-01-11
CA2624621A1 (en) 2007-05-10
IL191059A0 (en) 2008-12-29
KR20080066073A (ko) 2008-07-15
AR057855A1 (es) 2007-12-19
US7572797B2 (en) 2009-08-11
CN101356169A (zh) 2009-01-28
WO2007052123A3 (en) 2007-07-12
AP2008004468A0 (en) 2008-06-30
NL2000284C2 (nl) 2007-09-28

Similar Documents

Publication Publication Date Title
NL300935I2 (nl) guselkumab.
NL2000323A1 (nl) Pyrimidine-derivaten.
NL1031741A1 (nl) Purinederivaten.
ATE520670T1 (de) Pyridazinderivate
NL1031385A1 (nl) Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
NL1031218A1 (nl) Oxyindoolderivaten.
NO20051199L (no) Rorhandteringsutstyr.
NL2000937A1 (nl) Piperidinederivaten.
DK3190106T3 (da) Desferrithiocinpolyether-analoger
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DK1971588T3 (da) Tiglien-3-onderivater
NO20053362D0 (no) Syklofuge.
NL1032046A1 (nl) Prostaglandinederivaten.
FR2892275B1 (fr) Poudrier.
ITMI20050051A1 (it) Fotodiodio organico di poli-9,9-diottil-fluorene
ATE541837T1 (de) Oxaphenanthren-derivate
FR2889804B1 (fr) Lit medicalise surbaisse.
ITRN20050016U1 (it) Struttura combinata.
DE602006019209D1 (de) Fluoroalkylpyrrolidin-derivate
ES1059992Y (es) Marco-estuche.
ES1059608Y (es) Percha-soporte.
ES1060970Y (es) Llavero-monedero.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20070727

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20100501